Dhampur Bio Organics
79.37
+0.36(+0.46%)
Market Cap₹524.50 Cr
PE Ratio37.33
Company Performance:
1D+0.46%
1M-5.09%
6M-12.14%
1Y-40.88%
5Y-52.78%
View Company Insightsright
Latest news about Dhampur Bio Organics
Dhampur Bio Organics Reports Q1 Loss Amid Revenue Growth; Sets Ambitious Targets 3 days ago
Dhampur Bio Organics Limited (DBOL) reported a 28.75% increase in Q1 revenue to ₹821.19 crore, but faced a net loss of ₹19.37 crore. EBITDA declined to ₹6.33 crore with margin contraction. Sugar segment revenue grew 22.09% but reported a loss. Bio Fuels & Spirits segment saw 83.55% revenue growth with reduced profit. Country Liquor segment showed improved revenue and profit. The company plans to improve distillery yields and expand into specialty chemicals for future growth.
Dhampur Bio Organics Reports 28.75% Revenue Growth to ₹821.19 Crores in Q1 Despite Profitability Challenges 4 days ago
Dhampur Bio Organics Secures Approval for Promoter Reclassification, Receives Warning for Disclosure Delay 7 days ago
Dhampur Bio Organics Expands Portfolio with UPML Launch Jul 02, 2025
Dhampur Bio Organics Enhances Distillery Capabilities with Dual Feed Upgrade Jun 05, 2025
More news about Dhampur Bio Organics
02May 25
Dhampur Bio Organics Reports Q4 Results: Improved Revenue and EBITDA, Declares Dividend
Dhampur Bio Organics released its Q4 FY2023 results, showing significant growth in key metrics. Revenue increased by 17.85% to ₹7,000.00 million, while EBITDA grew by 19.39% to ₹985.00 million. The EBITDA margin slightly improved to 14.00%. However, net profit saw a minor decline of 3.64% to ₹39.70 million. The company has declared a dividend of ₹1.25 per equity share.
02Apr 25
Dhampur Bio Organics Unveils Major Changes: Capacity Boost and Rebranding as Divija Bio Organics
Dhampur Bio Organics Limited has approved three significant changes: 1) Increasing country liquor production capacity to 8 million cases per year at its Asmoli unit. 2) Rebranding to Divija Bio Organics Limited, pending shareholder approval. 3) Implementing an Employee Stock Option Scheme for 2025, offering up to 33,19,350 equity shares to eligible employees and directors.
Dhampur Bio Organics
79.37
+0.36
(+0.46%)
1 Year Returns:-40.88%
Industry Peers